Bacterial Biofilms and Antibiotic Resistance: Molecular Mechanisms and Emerging Therapeutic Strategies

Authors

Alyaa Mohammed Hasan Alghazi

Dhi Qar Directorate of Education, 64001 Nasiriyah, Dhi Qar, Iraq. (Iraq)

Intisar Amer Hashim

Dhi Qar Directorate of Education, 64001 Nasiriyah, Dhi Qar, Iraq. (Iraq)

Mohammed N. F. Albadri

College of Pharmacy, Al-Ayen Iraqi University, AUIQ, 64001 Nasiriyah, Dhi Qar, Iraq. (Iraq)

Ahmed Alamiery

College of Pharmacy, Al-Ayen Iraqi University, AUIQ, 64001 Nasiriyah, Dhi Qar, Iraq. (Iraq)

Article Information

DOI: 10.51584/IJRIAS.2026.11100093

Subject Category: Biology

Volume/Issue: 11/10 | Page No: 1394-1405

Publication Timeline

Submitted: 2026-10-24

Accepted: 2026-10-29

Published: 2026-11-16

Abstract

Bacterial biofilms are spatially organized microbial communities whose extracellular matrix and physiological heterogeneity complicate the treatment of persistent infections. This review examines molecular mechanisms underlying biofilm-associated antibiotic resistance and tolerance and evaluates emerging therapeutic strategies in relation to their experimental evidence and translational limitations. Biofilm recalcitrance results from interacting processes rather than a universal protective mechanism. Extracellular polymeric substances influence antimicrobial distribution and host interactions, while oxygen and nutrient gradients generate physiologically distinct populations with variable antibiotic susceptibility. Regulatory signaling, efflux systems, stress responses, persister cells, and the selection or exchange of resistance determinants further contribute to survival. Importantly, heritable antibiotic resistance must be distinguished from phenotypic tolerance and persistence, which can reduce bacterial killing without necessarily increasing minimum inhibitory concentrations. Emerging approaches include matrix-disrupting enzymes, quorum-sensing and antivirulence inhibitors, antimicrobial peptides, nanocarrier-based delivery, bacteriophages, persister-directed interventions, and mechanism-guided combination treatments. Although these strategies demonstrate promise in laboratory and selected preclinical models, their clinical utility remains constrained by species-specific effects, biofilm heterogeneity, safety considerations, and limited comparative human evidence. Progress will require standardized viability and regrowth endpoints, infection-relevant models, and rigorous evaluation alongside established antimicrobial treatment and source control. A mechanism-informed, infection-specific approach may improve the development and assessment of therapies for biofilm-associated infections.

Keywords

Bacterial biofilms; antibiotic resistance; antibiotic tolerance; persister cells; extracellular polymeric substances; antibiofilm therapy; bacteriophages.

Downloads

References

1. Flemming HC, Wingender J. The biofilm matrix. Nat Rev Microbiol. 2010;8:623–633. doi:10.1038/nrmicro2415. [Google Scholar] [Crossref]

2. Donlan RM, Costerton JW. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev. 2002;15(2):167–193. doi:10.1128/CMR.15.2.167-193.2002. [Google Scholar] [Crossref]

3. Rabin N, Zheng Y, Opoku-Temeng C, Du Y, Bonsu E, Sintim HO. Biofilm formation mechanisms and targets for developing antibiofilm agents. Future Med Chem. 2015;7(4):493–512. [Google Scholar] [Crossref]

4. doi:10.4155/fmc.15.6. [Google Scholar] [Crossref]

5. Papenfort K, Bassler BL. Quorum sensing signal–response systems in Gram-negative bacteria. Nat Rev Microbiol. 2016;14:576–588. doi:10.1038/nrmicro.2016.89. [Google Scholar] [Crossref]

6. Gunn JS, Bakaletz LO, Wozniak DJ. What's on the outside matters: the role of the extracellular polymeric substance of Gram-negative biofilms in evading host immunity and as a target for therapeutic intervention. J Biol Chem. 2016;291(24):12538–12546. doi:10.1074/jbc.R115.707547. [Google Scholar] [Crossref]

7. Brackman G, Coenye T. Quorum sensing inhibitors as anti-biofilm agents. Curr Pharm Des. 2015;21(1):5–11. doi:10.2174/1381612820666140905114627. [Google Scholar] [Crossref]

8. Mah TF. Biofilm-specific antibiotic resistance. Future Microbiol. 2012;7(9):1061–1072. [Google Scholar] [Crossref]

9. doi:10.2217/fmb.12.76. [Google Scholar] [Crossref]

10. Brooun A, Liu S, Lewis K. A dose-response study of antibiotic resistance in Pseudomonas aeruginosa biofilms. Antimicrob Agents Chemother. 2000;44(3):640–646. doi:10.1128/AAC.44.3.640-646.2000. [Google Scholar] [Crossref]

11. Alav I, Sutton JM, Rahman KM. Role of bacterial efflux pumps in biofilm formation. J Antimicrob Chemother. 2018;73(8):2003–2020. doi:10.1093/jac/dky042. [Google Scholar] [Crossref]

12. Lewis K. Persister cells. Annu Rev Microbiol. 2010;64:357–372. [Google Scholar] [Crossref]

13. doi:10.1146/annurev.micro.112408.134306. [Google Scholar] [Crossref]

14. Singh R, Ray P, Das A, Sharma M. Role of persisters and small-colony variants in antibiotic resistance of planktonic and biofilm-associated Staphylococcus aureus: an in vitro study. J Med Microbiol. 2009;58:1067–1073. doi:10.1099/jmm.0.009720-0. [Google Scholar] [Crossref]

15. Roberts ME, Stewart PS. Modelling protection from antimicrobial agents in biofilms through the formation of persister cells. Microbiology. 2005;151:75–80. doi:10.1099/mic.0.27385-0. [Google Scholar] [Crossref]

16. Verderosa AD, Totsika M, Fairfull-Smith KE. Bacterial biofilm eradication agents: a current review. Front Chem. 2019;7:824. doi:10.3389/fchem.2019.00824. [Google Scholar] [Crossref]

17. Koo H, Allan RN, Howlin RP, Stoodley P, Hall-Stoodley L. Targeting microbial biofilms: current and prospective therapeutic strategies. Nat Rev Microbiol. 2017;15:740–755. doi:10.1038/nrmicro.2017.99. [Google Scholar] [Crossref]

18. Defraine V, Fauvart M, Michiels J. Fighting bacterial persistence: current and emerging anti-persister strategies and therapeutics. Drug Resist Updat. 2018;38:12–26. doi:10.1016/j.drup.2018.03.002. [Google Scholar] [Crossref]

19. Kok LC, Tsai CC, Liao YH, Lo YL, Cheng NW, Lin CT, Chang HY. Roles of transcriptional factor PsrA in the regulation of quorum sensing in Pseudomonas aeruginosa PAO1. Front Microbiol. 2024;15:1424330. doi:10.3389/fmicb.2024.1424330. [Google Scholar] [Crossref]

20. Balkrishna A, Ngpoore NK, Bhatti S, Varshney Y, Kabdwal M, Nain P, et al. Linolenic acid-enriched supercritical carbon dioxide extract from seeds of Phyllanthus emblica L., a functional food with quorum quenching and anti-biofilm action, rescues Caenorhabditis elegans infection model from Pseudomonas aeruginosa. Appl Food Res. 2025;5:101244. doi:10.1016/j.afres.2025.101244. [Google Scholar] [Crossref]

21. Satpathy S, Sen SK, Pattanaik S, Raut S. Review on bacterial biofilm: an universal cause of contamination. Biocatal Agric Biotechnol. 2016. doi:10.1016/j.bcab.2016.05.002. [Google Scholar] [Crossref]

22. Stewart PS. Diffusion in biofilms. J Bacteriol. 2003;185:1485–1491. doi:10.1128/JB.185.5.1485-1491.2003. [Google Scholar] [Crossref]

23. Walters MC III, Roe F, Bugnicourt A, Franklin MJ, Stewart PS. Contributions of antibiotic penetration, oxygen limitation, and low metabolic activity to tolerance of Pseudomonas aeruginosa biofilms to ciprofloxacin and tobramycin. Antimicrob Agents Chemother. 2003;47:317–323. [Google Scholar] [Crossref]

24. doi:10.1128/AAC.47.1.317-323.2003. [Google Scholar] [Crossref]

25. Hall CW, Mah TF. Molecular mechanisms of biofilm-based antibiotic resistance and tolerance in pathogenic bacteria. FEMS Microbiol Rev. 2017;41:276–301. doi:10.1093/femsre/fux010. [Google Scholar] [Crossref]

26. Uruén C, Chopo-Escuin G, Tommassen J, Mainar-Jaime RC, Arenas J. Biofilms as promoters of bacterial antibiotic resistance and tolerance. Antibiotics. 2021;10:3. doi:10.3390/antibiotics10010003. [Google Scholar] [Crossref]

27. Grari O, Ezrari S, El Yandouzi I, Benaissa E, Ben Lahlou Y, Lahmer M, et al. A comprehensive review on biofilm-associated infections: mechanisms, diagnostic challenges, and innovative therapeutic strategies. The Microbe. 2025;8:100436. doi:10.1016/j.microb.2025.100436. [Google Scholar] [Crossref]

28. Spoering AL, Lewis K. Biofilms and planktonic cells of Pseudomonas aeruginosa have similar resistance to killing by antimicrobials. J Bacteriol. 2001;183:6746–6751. doi:10.1128/JB.183.23.6746-6751.2001. [Google Scholar] [Crossref]

29. Pamp SJ, Gjermansen M, Johansen HK, Tolker-Nielsen T. Tolerance to the antimicrobial peptide colistin in Pseudomonas aeruginosa biofilms is linked to metabolically active cells, and depends on the pmr and mexAB-oprM genes. Mol Microbiol. 2008;68:223–240. [Google Scholar] [Crossref]

30. doi:10.1111/j.1365-2958.2008.06152.x. [Google Scholar] [Crossref]

31. Bernier SP, Lebeaux D, DeFrancesco AS, Valomon A, Soubigou G, Coppée JY, et al. Starvation, together with the SOS response, mediates high biofilm-specific tolerance to the fluoroquinolone ofloxacin. PLoS Genet. 2013;9:e1003144. doi:10.1371/journal.pgen.1003144. [Google Scholar] [Crossref]

32. Hansen S, Lewis K, Vulić M. Role of global regulators and nucleotide metabolism in antibiotic tolerance in Escherichia coli. Antimicrob Agents Chemother. 2008;52:2718–2726. [Google Scholar] [Crossref]

33. doi:10.1128/AAC.00144-08. [Google Scholar] [Crossref]

34. Keren I, Shah D, Spoering A, Kaldalu N, Lewis K. Specialized persister cells and the mechanism of multidrug tolerance in Escherichia coli. J Bacteriol. 2004;186:8172–8180. [Google Scholar] [Crossref]

35. doi:10.1128/JB.186.24.8172-8180.2004. [Google Scholar] [Crossref]

36. Golmoradi Zadeh R, Sadeghi Kalani B, Mahdizade Ari M, Talebi M, Razavi S, Masjedian Jazi F. Isolation of persister cells within the biofilm and relative gene expression analysis of type II toxin/antitoxin system in Pseudomonas aeruginosa isolates in exponential and stationary phases. J Glob Antimicrob Resist. 2022;28:30–37. doi:10.1016/j.jgar.2021.11.009. [Google Scholar] [Crossref]

37. Patel H, Buchad H, Gajjar D. Pseudomonas aeruginosa persister cell formation upon antibiotic exposure in planktonic and biofilm state. Sci Rep. 2022;12:16151. doi:10.1038/s41598-022-20323-3. [Google Scholar] [Crossref]

38. Amraei F, Narimisa N, Sadeghi Kalani B, Lohrasbi V, Masjedian Jazi F. Persister cells formation and expression of type II toxin-antitoxin system genes in Brucella melitensis (16M) and Brucella abortus (B19). Iran J Pathol. 2020;15:127–133. doi:10.30699/ijp.2020.118902.2294. [Google Scholar] [Crossref]

39. Merfa MV, Niza B, Takita MA, De Souza AA. The MqsRA toxin-antitoxin system from Xylella fastidiosa plays a key role in bacterial fitness, pathogenicity, and persister cell formation. Front Microbiol. 2016;7:904. doi:10.3389/fmicb.2016.00904. [Google Scholar] [Crossref]

40. Babosan A, Gaschet M, Muggeo A, Jové T, Skurnik D, Ploy MC, et al. A qnrD-plasmid promotes biofilm formation and class 1 integron gene cassette rearrangements in Escherichia coli. Antibiotics. 2022;11:715. doi:10.3390/antibiotics11060715. [Google Scholar] [Crossref]

41. Schroeder M, Brooks BD, Brooks AE. The complex relationship between virulence and antibiotic resistance. Genes. 2017;8:39. doi:10.3390/genes8010039. [Google Scholar] [Crossref]

42. Martínez JL, Sánchez MB, Martínez-Solano L, Hernández A, Garmendia L, Fajardo A, Alvarez-Ortega C. Functional role of bacterial multidrug efflux pumps in microbial natural ecosystems. FEMS Microbiol Rev. 2009;33:430–449. doi:10.1111/j.1574-6976.2008.00157.x. [Google Scholar] [Crossref]

43. Grooters KE, Ku JC, Richter DM, Krinock MJ, Minor A, Li P, et al. Strategies for combating antibiotic resistance in bacterial biofilms. Front Cell Infect Microbiol. 2024;14:1352273. [Google Scholar] [Crossref]

44. doi:10.3389/fcimb.2024.1352273. [Google Scholar] [Crossref]

45. Singh P, Arsi L. Pseudomonas aeruginosa biofilms: pathogenicity, clinical challenges and emerging therapeutic strategies. The Microbe. 2026;10:100645. doi:10.1016/j.microb.2025.100645. [Google Scholar] [Crossref]

46. Chua SL, Yam JKH, Hao P, Adav SS, Salido MM, Liu Y, et al. Selective labelling and eradication of antibiotic-tolerant bacterial populations in Pseudomonas aeruginosa biofilms. Nat Commun. 2016;7:10750. doi:10.1038/ncomms10750. [Google Scholar] [Crossref]

Metrics

Views & Downloads

Similar Articles